CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Parks Diane L. Director | Grant or award | +199,921 | 236,066 | ||
| 2023-06-14 | Parks Diane L. Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2023-06-14 | Kehler Dean C Director | Grant or award | +199,921 | 236,066 | ||
| 2023-06-14 | Kehler Dean C Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2023-06-14 | Smith Robin L Director | Grant or award | +199,921 | 236,066 | ||
| 2023-06-14 | Smith Robin L Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2023-06-14 | Mazur Marc Director | Grant or award | +199,921 | 236,066 | ||
| 2023-06-14 | Mazur Marc Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2023-06-14 | VON ESCHENBACH ANDREW C. Director | Grant or award | +199,921 | 336,066 | ||
| 2023-06-14 | VON ESCHENBACH ANDREW C. Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2023-06-14 | SCULLEY JOHN Director | Grant or award | +199,921 | 1,004,660 | ||
| 2023-06-14 | SCULLEY JOHN Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2023-06-14 | Diamandis Peter Director | Grant or award | +199,921 | 1,307,066 | ||
| 2023-06-14 | Diamandis Peter Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2023-06-14 | Lim Kok Thay Director | Grant or award | +199,921 | 236,066 | ||
| 2023-06-14 | Lim Kok Thay Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2023-04-13 | Brigido Stephen Pres, Functional Regeneration | Shares withheld for taxes | −2,683 | $0.71 | $2K | 230,126 |
| 2023-04-13 | Fletcher Kyle See Remarks | Shares withheld for taxes | −201 | $0.71 | $144 | 256,799 |
| 2023-04-13 | Hariri Robert J Chief Executive Officer | Shares withheld for taxes | −11,540 | $0.71 | $8K | 10,148,310 |
| 2023-04-13 | Beers David C Chief Financial Officer | Shares withheld for taxes | −3,606 | $0.71 | $3K | 287,405 |
Page 8 of 15 · 299 trades